Correlation Between Eterna Therapeutics and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on Eterna Therapeutics and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Mersana Therapeutics.
Diversification Opportunities for Eterna Therapeutics and Mersana Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eterna and Mersana is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Eterna Therapeutics and Mersana Therapeutics
Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Mersana Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Eterna Therapeutics is 1.06 times less risky than Mersana Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Mersana Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 197.00 in Mersana Therapeutics on September 12, 2024 and sell it today you would earn a total of 71.00 from holding Mersana Therapeutics or generate 36.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eterna Therapeutics vs. Mersana Therapeutics
Performance |
| Timeline |
| Eterna Therapeutics |
| Mersana Therapeutics |
Eterna Therapeutics and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eterna Therapeutics and Mersana Therapeutics
The main advantage of trading using opposite Eterna Therapeutics and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Eterna Therapeutics vs. Equillium | Eterna Therapeutics vs. DiaMedica Therapeutics | Eterna Therapeutics vs. Valneva SE ADR | Eterna Therapeutics vs. Vivani Medical |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |